Combining Therapeutic Plasma Exchange with Virus Neutralizing Antibodies for Treatment of Severe COVID-19 - Abstract
The pandemic spread of coronavirus disease 2019 (COVID-19)
caused by the severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) requires very urgently to identify effective
therapies and prophylaxis. After early promise, disappointing
findings have been reported with drugs repurposed for COVID-19,
including hydroxychloroquine